Kunitada Shimotohno

Title: Kunitada Shimotohno: Innovator in Nucleic Acid Research

Introduction

Kunitada Shimotohno is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of nucleic acid research, particularly in relation to hepatitis C virus (HCV) detection and inhibition. With a total of 3 patents, his work has advanced the understanding and management of viral infections.

Latest Patents

One of Shimotohno's latest patents focuses on the nucleic acid of the C type hepatitis virus. The objective of this invention is to clarify the sequence of the 3'-end site of the HCV genome and to provide a new process for detecting HCV. A new sequence with a highly conserved 3'-end site of the HCV genome has been identified. This discovery has led to the development of new processes for detecting HCV and inhibiting its proliferation. Another significant patent involves double-stranded DNA characterized by having sequences complementary to a single-stranded DNA derived from mungbean yellow mosaic virus. This invention includes a detailed restriction endonuclease cleavage map, which is crucial for further research and applications.

Career Highlights

Throughout his career, Kunitada Shimotohno has worked with prominent companies such as Teijin Limited and Rational Drug Design Laboratories. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Tsuto Morinaga and Kin-ichiro Miura. Their collaborative efforts have further enriched the research landscape in which Shimotohno operates.

Conclusion

Kunitada Shimotohno's innovative work in nucleic acid research has made a significant impact on the detection and treatment of viral infections. His patents reflect a commitment to advancing scientific knowledge and improving public health outcomes.